重编程
过剩1
葡萄糖转运蛋白
肿瘤微环境
糖酵解
细胞生物学
厌氧糖酵解
葡萄糖摄取
T细胞
免疫系统
细胞毒性T细胞
效应器
化学
生物
细胞
生物化学
新陈代谢
免疫学
体外
内分泌学
胰岛素
作者
Justin Arredondo-Guerrero,Dorota D. Klysz,Yiyun Chen,Meena Malipatlolla,Jameel Lone,Carley Fowler,Lucille Stuani,Audre May,Malek Bashti,Peng Xu,Jing Huang,Basil Michael,Kévin Contrepois,Shaurya Dhingra,Chris Fisher,Katrin J. Svensson,Kara L. Davis,Maya Kasowski,Steven A. Feldman,Elena Sotillo
标识
DOI:10.1038/s41467-024-52666-y
摘要
Abstract The intensive nutrient requirements needed to sustain T cell activation and proliferation, combined with competition for nutrients within the tumor microenvironment, raise the prospect that glucose availability may limit CAR-T cell function. Here, we seek to test the hypothesis that stable overexpression (OE) of the glucose transporter GLUT1 in primary human CAR-T cells would improve their function and antitumor potency. We observe that GLUT1OE in CAR-T cells increases glucose consumption, glycolysis, glycolytic reserve, and oxidative phosphorylation, and these effects are associated with decreased T cell exhaustion and increased Th 17 differentiation. GLUT1OE also induces broad metabolic reprogramming associated with increased glutathione-mediated resistance to reactive oxygen species, and increased inosine accumulation. When challenged with tumors, GLUT1OE CAR-T cells secrete more proinflammatory cytokines and show enhanced cytotoxicity in vitro, and demonstrate superior tumor control and persistence in mouse models. Our collective findings support a paradigm wherein glucose availability is rate limiting for effector CAR-T cell function and demonstrate that enhancing glucose availability via GLUT1OE could augment antitumor immune function.
科研通智能强力驱动
Strongly Powered by AbleSci AI